ATC
BVS icon

Adirondack Trust Company’s Bioventus BVS Stock Holding History

Adirondack Trust Company’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67K Sell
601
-24
-4% -$229 ﹤0.01% 469
2026
Q1 		$5.71K Hold
625
– – ﹤0.01% 440
2025
Q4 		$4.65K Hold
625
– – ﹤0.01% 454
2025
Q3 		$4.18K Sell
625
-57
-8% -$396 ﹤0.01% 447
2025
Q2 		$4.51K Hold
682
– – ﹤0.01% 413
2025
Q1 		$6.24K Hold
682
– – ﹤0.01% 391
2024
Q4 		$7.16K Hold
682
– – ﹤0.01% 385
2024
Q3 		$8.15K Hold
682
– – ﹤0.01% 380
2024
Q2 		$3.92K Hold
682
– – ﹤0.01% 420
2024
Q1 		$3.55K Hold
682
– – ﹤0.01% 432
2023
Q4 		$3.16K Buy
+682
New +$2.7K ﹤0.01% 437

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adirondack Trust Company's BVS Position: Q2 2026 in Review

Adirondack Trust Company reduced its Bioventus (BVS) stake by 3.8% in Q2 2026, selling an estimated $229 and leaving 601 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Adirondack Trust Company first reported a position in BVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.15K in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Adirondack Trust Company held 601 shares of Bioventus worth $5.67K as of Q2 2026.
  • Adirondack Trust Company sold 24 Bioventus shares in Q2 2026, an estimated $229.
  • Bioventus made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #469 holding.
  • Adirondack Trust Company first reported a position in Bioventus in Q4 2023 and has held it in 11 quarters since.
  • Adirondack Trust Company's Bioventus position peaked at $8.15K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.